Sign in / Join Now
ETFs & Funds
I find it interesting Orexigen Therapeutics' (
) estimates were raised eventhough it has no drug on market. Or am I missing something?
Add a reply...
Latest StockTalks »
people get OREX breaking news and analysis by email alert.
Get email alerts on OREX »
Orexigen Therapeutics, Inc.
Get latest price
From other sites
Orexigen Therapeutics (OREX) Shares March Higher, Can It Continue?
at Zacks.com (Jan 10, 2017)
Orexigen Therapeutics Announces Publication Of Contrave® (naltrexone HCl And Bupropion HCl Extended-release Tablets) Real-World Study Results In "Obesity"
at TheStreet (Jan 6, 2017)
Orexigen Therapeutics Highlights Key Business Priorities For 2017
at TheStreet (Jan 5, 2017)
Orexigen Therapeutics Launches "Brains Behind Weight Loss," A Dynamic Patient Focused Campaign To Educate Consumers On The Role Of The Brain In Weight Loss
at TheStreet (Jan 3, 2017)
Orexigen Therapeutics Announces Commercialization And Distributorship Agreement With Biologix FZCO For Contrave® (naltrexone HCl / Bupropion HCl Prolonged Release) For Ten Countries In The Middle East
at TheStreet (Dec 19, 2016)